Solution structure of the esperamicin A1-DNA complex.

Esperamicin A1 is an enediyne antibiotic possessing antitumor activity associated with its ability to bind and, following activation, affect strand cleavage of DNA. We report on the solution structure of the esperamicin A1-d(C-G-G-A-T-C-C-G) duplex complex based on a combined analysis of NMR and molecular dynamics calculations including intensity refinement in a water box. The refined solution structures of the complex provide a molecular explanation of the sequence specificity for binding and cleavage by this member of the enediyne family of antitumor antibiotics. Esperamicin A1 binds to the DNA minor groove with its methoxyacrylyl-anthranilate moiety intercalating into the helix at the (G2-G3)-(C6'-C7') step. The methoxyacrylyl-anthranilate intercalator and the minor groove binding A-B-C+ risaccharide moieties rigidly anchor the enediyne in the minor groove such that the pro-radical centers of the enediyne are proximal to their anticipated proton abstraction sites. Specifically, the pro-radical C-3 and C-6 atoms are aligned opposite the abstractable H-5' (pro-S) proton of C6 and the H-1' proton of C6' on partner strands, respectively, in the complex. The thiomethyl sugar B residue is buried deep in an edgewise manner in the minor groove with its two faces sandwiched between the walls of the groove. Further, the polarizable sulfur atom of the thiomethyl group of sugar B residue is positioned opposite and can hydrogen-bond to the exposed amino proton of G3' in the complex. There is little perturbation away from a right-handed Watson-Crick base-paired duplex in the complex other than unwinding of the helix at the intercalation site and widening of the minor groove centered about the enediyne-binding and anthranilate intercalation sites. Sequence-specific binding of esperamicin A1 to the d(C-G-G-A-T-C-C-G) duplex is favored by the complementarity of the fit between the drug and the floor of the minor groove, good stacking between the intercalating anthranilate ring and flanking purine bases and intermolecular hydrogen-bonding interactions.

[1]  P. Dedon,et al.  The deoxyfucose-anthranilate of esperamicin A1 confers intercalative DNA binding and causes a switch in the chemistry of bistranded DNA lesions. , 1994 .

[2]  Y. Sugiura,et al.  Nucleotide-specific cleavage and minor-groove interaction of DNA with esperamicin antitumor antibiotics. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. Walker,et al.  Structural characterization of a calicheamicin-DNA complex by NMR , 1993 .

[4]  A. Majumdar,et al.  Simulation of 2D NMR spectra for determination of solution conformations of nucleic acids , 1992 .

[5]  H. Kawaguchi,et al.  Esperamicins, a novel class of potent antitumor antibiotics. I. Physico-chemical data and partial structure. , 1985, The Journal of antibiotics.

[6]  V. Saudek,et al.  Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions , 1992, Journal of biomolecular NMR.

[7]  A. Bax,et al.  Measurement of proton phosphorus 31 nmr coupling constants in double stranded dna fragments , 1987 .

[8]  R Lavery,et al.  The definition of generalized helicoidal parameters and of axis curvature for irregular nucleic acids. , 1988, Journal of biomolecular structure & dynamics.

[9]  C. Townsend,et al.  Specific abstraction of the 5'S- and 4'-deoxyribosyl hydrogen atoms from DNA by calicheamicin .gamma.1I , 1992 .

[10]  A. J. Shaka,et al.  Computer-optimized decoupling scheme for wideband applications and low-level operation , 1985 .

[11]  A. Bax,et al.  Assignment of the 31P and 1H resonances in oligonucleotides by two‐dimensional NMR spectroscopy , 1986, FEBS letters.

[12]  J. Catino,et al.  Esperamicins, a class of potent antitumor antibiotics: mechanism of action. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Patel,et al.  Calicheamicin-DNA complexes: warhead alignment and saccharide recognition of the minor groove. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Y. Sugiura,et al.  Heat-induced DNA cleavage by esperamicin antitumor antibiotics. , 1991, Biochemistry.

[15]  西村 善文.  W. Saenger: Principles of Nucleic Acid Structure, Springer-Verlag, New York and Berlin, 1984, xx+556ページ, 24.5×16.5cm, 14,160円 (Springer Advanced Texts in Chemistry). , 1985 .

[16]  J. Goodisman,et al.  Coupled Kinetic Analysis of Cleavage of DNA by Esperamicin and Calicheamicin , 1991 .

[17]  R. Griffey,et al.  Correlation of proton and nitrogen-15 chemical shifts by multiple quantum NMR☆ , 1983 .

[18]  D. States,et al.  A two-dimensional nuclear overhauser experiment with pure absorption phase in four quadrants☆ , 1982 .

[19]  Y. Sugiura,et al.  Light-induced DNA cleavage by esperamicin and neocarzinostatin. , 1989, Biochemical and biophysical research communications.

[20]  C. W. Hilbers,et al.  Nucleic acids and nuclear magnetic resonance. , 1988, European journal of biochemistry.

[21]  J. Stubbe,et al.  Unmasking the chemistry of DNA cleavage by the esperamicins : modulation of 4'-hydrogen abstraction and bistranded damage by the fucose-anthranilate moiety , 1992 .

[22]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[23]  D. Beveridge,et al.  The DNA-esperamicin A1 complex. A model based on solvated molecular dynamics simulations , 1994 .

[24]  D. Patel,et al.  Solution structure of the mithramycin dimer-DNA complex. , 1993, Biochemistry.

[25]  K. Nicolaou,et al.  Interaction of Calicheamicin with Duplex DNA: Role of the Oligosaccharide Domain and Identification of Multiple Binding Modes , 1994 .

[26]  H. Kawaguchi,et al.  Esperamicins, a novel class of potent antitumor antibiotics. 3. Structures of esperamicins A1, A2, and A1b , 1987 .

[27]  J. Xu,et al.  Exclusive production of bistranded DNA damage by calicheamicin. , 1993, Biochemistry.

[28]  M. Uesugi,et al.  New insights into sequence recognition process of esperamicin A1 and calicheamicin gamma 1I.: origin of their selectivities and "induced fit" mechanism. , 1993, Biochemistry.